GEMCITABINE (Sun Pharma Global FZE)
Welcome to the PulseAid listing for the GEMCITABINE drug offered from Sun Pharma Global FZE. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sun Pharma Global FZE |
| NON-PROPRIETARY NAME: | GEMCITABINE HYDROCHLORIDE |
| SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-07-25 |
| END MARKETING DATE: | 2018-09-30 |
GEMCITABINE HUMAN PRESCRIPTION DRUG Details:
| Item Description | GEMCITABINE from Sun Pharma Global FZE |
| LABELER NAME: | Sun Pharma Global FZE |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/5mL) |
| START MARKETING DATE: | 2011-07-25 |
| END MARKETING DATE: | 2018-09-30 |
| PRODUCT ID: | 47335-153_9a1ae8f9-ea15-40fc-ba3e-e7a07cd0b705 |
| PRODUCT NDC: | 47335-153 |
| APPLICATION NUMBER: | ANDA078433 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
